Zdrowie i gospodarka · 25/04/1997

Cellpro, Inc.; Premarket Approval of CEPRATERegister SC Stem Cell Concentration System

The Food and Drug Administration (FDA) is announcing its approval of the application by CellPro, Inc., Bothell, WA, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of the CEPRATE SC Stem Cell Concentration System (CEPRATE SC System). FDA's Center for Biologics Evaluation and Research (CBER) notified the applicant, by letter of December 6, 1996, of the approval of the application.